US Stock MarketDetailed Quotes

BMRN Biomarin Pharmaceutical

Watchlist
  • 65.890
  • -0.790-1.18%
Close Oct 31 16:00 ET
  • 65.890
  • 0.0000.00%
Post 20:01 ET
12.56BMarket Cap39.69P/E (TTM)

Biomarin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Biomarin Pharmaceutical Q3 2024 Earnings Date

Currency：USDOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
703.31M
745.74M
+42.43M
Beat Est.
+20.98%
+28.28%
+6.03%
EPS
0.52
0.55
+0.03
Beat Est.
+148.10%
+161.90%
+5.57%
Analyst Rating
Buy

Oct 31, 2024

Biomarin Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 725.042M--
--2024/Q4-- / 710.131M--
Oct 29, 20242024/Q3745.740M / 703.312M--
Aug 5, 20242024/Q2712.029M / 664.008M--
Apr 24, 20242024/Q1648.833M / 651.814M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 725.042M--
--2024/Q4-- / 710.131M--
Oct 29, 20242024/Q3745.740M / 703.312M--
Aug 5, 20242024/Q2712.029M / 664.008M--
Apr 24, 20242024/Q1648.833M / 651.814M--

Unlock Free Earnings Estimates

Biomarin Pharmaceutical Earnings Reports

  • Biomarin Pharmaceutical | 10-Q: Quarterly report

    15:06 ET

  • Biomarin Pharmaceutical | 10-Q: Q2 2024 Earnings Report

    Aug 5 16:38 ET

  • Biomarin Pharmaceutical | 10-Q: Q1 2024 Earnings Report

    Apr 26 14:04 ET

  • Biomarin Pharmaceutical | 10-K: FY2023 Annual Report

    Feb 26 13:36 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Buy

    • Buy

      71.43%

    • Hold

      28.57%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data